पदोन्नति कार्यक्रम Aura Biosciences, Inc.
उन्नत शेड्यूल
सरल ग्राफ
कंपनी के बारे में Aura Biosciences, Inc.
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for treating tumors of high unmet need in ocular and urologic oncology. It is developing AU-011, a VDC candidate for the treatment of primary choroidal melanoma that is in phase III clinical trial. The company also develops AU-011 for additional ocular oncology indications, including choroidal metastases and is in Phase 2 dose-escalation trial. अधिक जानकारीIPO date | 2021-10-29 |
---|---|
ISIN | US05153U1079 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.aurabiosciences.com |
Цена ао | 5.99 |
प्रति दिन मूल्य परिवर्तन: | +5.39% (5.94) |
---|---|
प्रति सप्ताह मूल्य परिवर्तन: | -16.53% (7.5) |
प्रति माह मूल्य परिवर्तन: | -16.53% (7.5) |
3 महीने में कीमत में बदलाव: | -24.85% (8.33) |
छह महीने में कीमत में बदलाव: | -29.74% (8.91) |
प्रति वर्ष मूल्य परिवर्तन: | -20.25% (7.85) |
3 वर्षों में मूल्य परिवर्तन: | -70.42% (21.16) |
वर्ष की शुरुआत से मूल्य परिवर्तन: | -24.85% (8.33) |
|
बहुत मूल्यवान समझना
|
क्षमता
|
|||||||||||||||||||||||||||||||||||||
लाभांश
|
कर्तव्य
|
विकास का आवेग
|
संस्थानों | आयतन | शेयर करना, % |
---|---|---|
Matrix Capital Management | 6922870 | 13.98 |
Eventide Asset Management LLC | 5802682 | 11.72 |
Adage Capital Partners GP L.L.C. | 4225000 | 8.53 |
Citadel Advisors Llc | 3631294 | 7.34 |
Medicxi Ventures Management (Jersey) Ltd | 3039892 | 6.14 |
Nantahala Capital Management, LLC | 2643720 | 5.34 |
Blackrock Inc. | 2098745 | 4.24 |
Vanguard Group Inc | 1730431 | 3.5 |
Decheng Capital Management III (Cayman), LLC | 1163123 | 2.35 |
Goldman Sachs Group Inc | 1037299 | 2.1 |
पर्यवेक्षक | नौकरी का शीर्षक | भुगतान | जन्म का साल |
---|---|---|---|
Dr. Elisabet de los Pinos Ph.D. | Founder, CEO, President & Director | 895.16k | 1974 (51 वर्ष) |
Ms. Julie B. Feder | Chief Financial Officer | 604.2k | 1971 (54 वर्ष) |
Dr. Mark Plavsic D.V.M., Ph.D. | Chief Technology Officer | N/A | 1961 (64 वर्ष) |
Mr. Patrick Nealon | Senior Vice President of Clinical Development Operations | N/A | |
Dr. Anthony Daniels M.D. | Therapeutic Area Head of Ocular Oncology | N/A | |
Dr. Richard Mountfield Ph.D. | Senior Vice President of Regulatory Affairs & Quality | N/A | |
Mr. Conor Kilroy | General Counsel & Secretary | N/A | 1982 (43 वर्ष) |
Dr. Jill J. Hopkins M.D. | Chief Medical Officer & President of Research and Development | N/A | 1965 (60 साल) |
पता: United States, Boston. MA, 80 Guest Street - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.aurabiosciences.com
वेबसाइट: https://www.aurabiosciences.com